CN Patent

CN116135871A — 一种具有抗耐药性的抗菌化合物

Assigned to Shijiazhuang Dikaiwei Pharmaceutical Technology Co ltd · Expires 2023-05-19 · 3y expired

What this patent protects

本发明涉及一类甾体衍生物及其制备方法、药物组合物和用途，所述的甾体衍生物如式(I 0 )所示，也包含该化合物的水合物、溶剂化物、同位素衍生物、非对映异构体或药学上可接受的盐；本发明化合物表现出较好的抗菌活性，且对多种耐药菌有效。在皮肤给药时表现出很好的皮肤组织内的分布和很低的全身暴露量。

USPTO Abstract

本发明涉及一类甾体衍生物及其制备方法、药物组合物和用途，所述的甾体衍生物如式(I 0 )所示，也包含该化合物的水合物、溶剂化物、同位素衍生物、非对映异构体或药学上可接受的盐；本发明化合物表现出较好的抗菌活性，且对多种耐药菌有效。在皮肤给药时表现出很好的皮肤组织内的分布和很低的全身暴露量。

Drugs covered by this patent

Patent Metadata

Patent number
CN116135871A
Jurisdiction
CN
Classification
—
Expires
2023-05-19
Drug substance claim
No
Drug product claim
No
Assignee
Shijiazhuang Dikaiwei Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.